Loading...
Market
How will public perception of Martin Shkreli change by end of 2024?
4
Resolution / Starting Odds
Improved perception • 25%
Worsened perception • 25%
Unchanged perception • 25%
Mixed perception • 25%
Media analysis reports or public opinion polls
Story
Supreme Court Rejects 'Pharma Bro' Shkreli's Appeal Over $64.6M Penalty for 4,000% Drug Price Hike
Oct 7, 2024, 03:21 PM
The U.S. Supreme Court declined to hear former pharmaceutical executive Martin Shkreli's appeal against a $64.6 million financial penalty imposed by a judge. Shkreli, infamously known as the 'Pharma Bro', had raised the price of a life-saving drug by more than 4,000%, increasing the cost by over $700 per pill. He was penalized for blocking competition to the drug. The decision leaves in place the antitrust judgment against him.
View original story
Similar markets
Mostly positive • 25%
Mostly negative • 25%
Mixed reactions • 25%
Little to no reaction • 25%
More positive • 25%
No change • 25%
More negative • 25%
Uncertain • 25%
Yes • 50%
No • 50%
Significantly more negative • 25%
Slightly more negative • 25%
No change • 25%
More positive • 25%
Politically motivated • 25%
Justified legal action • 25%
Mixed opinions • 25%
Largely indifferent • 25%
More Favorable • 33%
Unchanged • 33%
Less Favorable • 34%
More Positive • 25%
More Negative • 25%
No Change • 25%
Mixed Opinions • 25%
Fully recovered • 25%
Partially recovered • 25%
Not recovered • 25%
Worsened • 25%
Increase • 25%
Decrease • 25%
No change • 25%
Other • 25%
Positive • 25%
Neutral • 25%
Negative • 25%
Mixed • 25%
Majority agree with Musk • 25%
Majority disagree with Musk • 25%
Public opinion remains unchanged • 25%
Insufficient data • 25%